EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,834 | +4.8% | 9,878 | 0.0% | 0.02% | -11.5% |
| Q2 2022 | $206,000 | -8.0% | 9,878 | 0.0% | 0.03% | 0.0% |
| Q1 2022 | $224,000 | +7.2% | 9,878 | 0.0% | 0.03% | +8.3% |
| Q3 2021 | $209,000 | -6.3% | 9,878 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $223,000 | -7.9% | 9,878 | 0.0% | 0.03% | -25.0% |
| Q3 2020 | $242,000 | +3.0% | 9,878 | 0.0% | 0.04% | -2.7% |
| Q2 2020 | $235,000 | +11.4% | 9,878 | 0.0% | 0.04% | +8.8% |
| Q2 2019 | $211,000 | -10.2% | 9,878 | 0.0% | 0.03% | -8.1% |
| Q1 2019 | $235,000 | +21.1% | 9,878 | 0.0% | 0.04% | +48.0% |
| Q4 2018 | $194,000 | +10.9% | 9,878 | 0.0% | 0.02% | -3.8% |
| Q3 2018 | $175,000 | -17.8% | 9,878 | 0.0% | 0.03% | -13.3% |
| Q2 2018 | $213,000 | – | 9,878 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |